{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06088979",
            "orgStudyIdInfo": {
                "id": "TOUR006-T01"
            },
            "secondaryIdInfos": [
                {
                    "id": "U1111-1308-4718",
                    "type": "OTHER",
                    "domain": "WHO Universal Trial Number (UTN)"
                }
            ],
            "organization": {
                "fullName": "Tourmaline Bio, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease",
            "officialTitle": "A Multicenter Phase 2b Randomized, Double-Masked, Placebo-Controlled Dose-Ranging Study of TOUR006 in Participants With Thyroid Eye Disease",
            "acronym": "spiriTED",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-to-investigate-efficacy-and-safety-of-in-participants-to-years-of-age-with-thyroid-eye-disease"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-02-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-02",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-02",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-03",
            "studyFirstSubmitQcDate": "2023-10-11",
            "studyFirstPostDateStruct": {
                "date": "2023-10-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-26",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-28",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Tourmaline Bio, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Phase 2b trial of TOUR006 in Thyroid Eye Disease (TED) to evaluate 20mg and 50mg doses against placebo given by a subcutaneous injection every eight weeks to TED patients who are in the active inflammatory phase of disease."
        },
        "conditionsModule": {
            "conditions": [
                "Thyroid Eye Disease"
            ],
            "keywords": [
                "TED",
                "Graves' Disease",
                "Thyroid Eye Disease",
                "Exophthalmos",
                "Eye Diseases",
                "Thyroid Diseases",
                "Graves' Ophthalmopathy",
                "Hyperthyroidism"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 81,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "TOUR006 - 20 MG",
                    "type": "EXPERIMENTAL",
                    "description": "In part A of the study, participants will receive a total of three 20 mg subcutaneous injections: 1 injection every 8 weeks (Day 1, Week 8, Week 16) followed by treatment in part B of the study based on proptosis response and rescue therapy use.",
                    "interventionNames": [
                        "Drug: TOUR006 - 20 MG"
                    ]
                },
                {
                    "label": "TOUR006 - 50 MG",
                    "type": "EXPERIMENTAL",
                    "description": "In part A of the study, participants will receive a total of three 50 mg subcutaneous injections: 1 injection every 8 weeks (Day 1, Week 8, Week 16) followed by treatment in part B of the study based on proptosis response and rescue therapy use.",
                    "interventionNames": [
                        "Drug: TOUR006 - 50 MG"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "In part A of the study, participants will receive a total of three Placebo subcutaneous injections: 1 injection every 8 weeks (Day 1, Week 8, Week 16) followed by treatment in part B of the study based on proptosis response and rescue therapy use.",
                    "interventionNames": [
                        "Other: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "TOUR006 - 20 MG",
                    "description": "TOUR006 20 MG",
                    "armGroupLabels": [
                        "TOUR006 - 20 MG"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Placebo",
                    "description": "Placebo",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "TOUR006 - 50 MG",
                    "description": "TOUR006 - 50 MG",
                    "armGroupLabels": [
                        "TOUR006 - 50 MG"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage of participants achieving a proptosis response defined as a \u22652 mm reduction in proptosis from baseline in the study eye without deterioration [\u22652 mm increase] of proptosis in the fellow eye and without need for rescue therapy/intervention).",
                    "timeFrame": "20 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Percentage of participants achieving a proptosis response with 20mg TOUR006 administered SC every 8 weeks or 50mg TOUR006 administered SC every 8 weeks.",
                    "timeFrame": "72 weeks"
                },
                {
                    "measure": "Percentage of participants attaining a complete or near complete response on the 7-point Clinical Activity Score (CAS).",
                    "timeFrame": "72 weeks"
                },
                {
                    "measure": "Percentage of participants attaining \u22651 grade decrease in diplopia.",
                    "timeFrame": "72 weeks"
                },
                {
                    "measure": "Incidence of Treatment Emergent Adverse Events by severity and Serious Adverse Events through Week 72.",
                    "timeFrame": "72 weeks"
                },
                {
                    "measure": "Mean change from baseline in serum trough concentration of TOUR006.",
                    "timeFrame": "72 weeks"
                },
                {
                    "measure": "Mean change from baseline in serum TSI.",
                    "timeFrame": "72 weeks"
                },
                {
                    "measure": "Percentage of participants with anti-drug antibodies.",
                    "timeFrame": "72 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Clinical diagnosis of Graves' disease associated with moderate to severe active TED\n* Onset of active TED symptoms within approximately 15 months\n* Proptosis (exophthalmos) \u22653 mm above the normal range per investigator judgment (based upon race and gender) for the study eye\n* CAS \u22654 (on the 7-item scale) for the study eye\n* Presence of TSI \\>130% of the normal reference standard or \\>0.55 IU/L (depending on assay method) and laboratory reference ranges\n\nAdditional inclusion criteria are defined in the study protocol.\n\nExclusion Criteria:\n\n* Anticipated need for intervention due to sight-threatening complications or other significant and acute deterioration in vision\n* Any previous treatment with teprotumumab or other agent that inhibits the IGF-1 receptor\n* History of systemic (eg, oral or IV) steroid use with a cumulative dose equivalent to \\>1 g of methylprednisolone for the treatment of TED. Previous oral steroid use with a cumulative dose of \u22641 g methylprednisolone (or equivalent dosage for other systemic corticosteroid) for the treatment of TED, however, is allowed if the corticosteroid was discontinued at least 6 weeks before baseline (Day 1) and completely tapered by Baseline (if applicable).\n* Systemic (oral or IV) corticosteroid use for conditions other than TED within 6 weeks of baseline (Day 1) or not completely tapered by baseline (if applicable).\n* Any major illness/condition or evidence of an unstable clinical condition that, in the investigator's judgment, will substantially increase the risk to the participant, or confound the interpretation of safety assessments, if they were to participate in the study\n* Any other condition that, in the opinion of the investigator, would impair the ability of the participant to comply with the study procedures or impair the ability to interpret data from the participant's participation in the study\n* Pregnant or lactating\n\nAdditional exclusion criteria are defined in the study protocol.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "80 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Tourmaline Bio",
                    "role": "CONTACT",
                    "phone": "347-773-2627",
                    "email": "clinicaltrialinquiries@tourmalinebio.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Clinical Trials",
                    "affiliation": "Tourmaline Bio",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Site - 0121",
                    "status": "RECRUITING",
                    "city": "Tucson",
                    "state": "Arizona",
                    "zip": "85712",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.22174,
                        "lon": -110.92648
                    }
                },
                {
                    "facility": "Site - 0116",
                    "status": "RECRUITING",
                    "city": "Pasadena",
                    "state": "California",
                    "zip": "91107",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.14778,
                        "lon": -118.14452
                    }
                },
                {
                    "facility": "Site - 0114",
                    "status": "RECRUITING",
                    "city": "San Diego",
                    "state": "California",
                    "zip": "92108",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.71533,
                        "lon": -117.15726
                    }
                },
                {
                    "facility": "Site - 0101",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Site - 0115",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33136",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Site - 0103",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33174",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Site - 0108",
                    "status": "RECRUITING",
                    "city": "Louisville",
                    "state": "Kentucky",
                    "zip": "40202",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.25424,
                        "lon": -85.75941
                    }
                },
                {
                    "facility": "Site - 0112",
                    "status": "RECRUITING",
                    "city": "Livonia",
                    "state": "Michigan",
                    "zip": "48152",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.36837,
                        "lon": -83.35271
                    }
                },
                {
                    "facility": "Site - 0104",
                    "status": "RECRUITING",
                    "city": "Chapel Hill",
                    "state": "North Carolina",
                    "zip": "27517",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.9132,
                        "lon": -79.05584
                    }
                },
                {
                    "facility": "Site - 0106",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77004",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Site - 0120",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78215",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Site - 0113",
                    "status": "RECRUITING",
                    "city": "Morgantown",
                    "state": "West Virginia",
                    "zip": "26506",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.62953,
                        "lon": -79.9559
                    }
                },
                {
                    "facility": "Site - 0401",
                    "status": "RECRUITING",
                    "city": "Amman",
                    "country": "Jordan",
                    "geoPoint": {
                        "lat": 31.95522,
                        "lon": 35.94503
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                },
                {
                    "id": "D000049970",
                    "term": "Graves Ophthalmopathy"
                },
                {
                    "id": "D000013959",
                    "term": "Thyroid Diseases"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000015785",
                    "term": "Eye Diseases, Hereditary"
                },
                {
                    "id": "D000006111",
                    "term": "Graves Disease"
                },
                {
                    "id": "D000005094",
                    "term": "Exophthalmos"
                },
                {
                    "id": "D000009916",
                    "term": "Orbital Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000006042",
                    "term": "Goiter"
                },
                {
                    "id": "D000006980",
                    "term": "Hyperthyroidism"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16718",
                    "name": "Thyroid Diseases",
                    "asFound": "Thyroid",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "asFound": "Eye Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26148",
                    "name": "Graves Ophthalmopathy",
                    "asFound": "Thyroid Eye Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9214",
                    "name": "Graves Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M10031",
                    "name": "Hyperthyroidism",
                    "relevance": "LOW"
                },
                {
                    "id": "M8237",
                    "name": "Exophthalmos",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M18339",
                    "name": "Eye Diseases, Hereditary",
                    "relevance": "LOW"
                },
                {
                    "id": "M12845",
                    "name": "Orbital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M9147",
                    "name": "Goiter",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                }
            ]
        }
    },
    "hasResults": false
}